Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients

AIM: The aim of this study was to investigate the association of hyperoncotic (20%) human albumin solution (HAS) with outcomes among critically ill patients receiving continuous renal replacement therapy (RRT). METHODS: Analysis of the Randomized Evaluation of Normal versus Augmented Level (RENAL) R...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, Zachary, Finnis, Mark, Gallagher, Martin, Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Critical Care Nephrology − Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393816/
https://www.ncbi.nlm.nih.gov/pubmed/34515056
http://dx.doi.org/10.1159/000517957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393816/
https://www.ncbi.nlm.nih.gov/pubmed/34515056
http://dx.doi.org/10.1159/000517957

Ejemplares similares